The controversy over vibe coding reached a new high this week after a developer added hidden instructions to his open source ...

The drops go beyond the pandemic and cut across income, geographic and racial divides, new data shows. By Claire Cain Miller Francesca Paris and Sarah Mervosh Something troubling is happening in U.S.

The promise of smart test is a data-chain problem before it is an algorithm problem. A device can pass every checkpoint and still carry a latent defect the test record never captured. As test grows ...

Trey Paul was a CNET senior editor covering broadband. His 20+ years of experience as a writer and editor include time at the broadband marketplace Allconnect, as well as working with clients like ...

Hyperscales are increasingly tapping private credit and debt markets to finance the build-out of AI data centers. The huge sums of money flowing into the sector pose both risks and rewards for ...

The vast data centers that power artificial intelligence guzzle huge amounts of energy but they also have another alarming impact, according to new research. They are creating “heat islands,” warming ...

Abstract: Generation of thorough test oracles is an open problem. Popular test case generators, like EvoSuite and Randoop, rely on implicit, rule-based, and regression oracles that miss failures that ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Now ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

President Donald Trump said on Tuesday during his State of the Union address that his administration has told major technology companies they must build their own power plants for their data centers, ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...